Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors to compensate victims ...

The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 billion over time.

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

Purdue Pharma, a Stamford-based drug maker that has faced billions in fines for misleading the public on its addictive opioid OxyContin, has received court approval to pay more than $7.4 […] ...

Forty-nine U.S. states have signed off on a $7 billion settlement with Purdue Pharma over its marketing of opioid drugs like its prescription Oxycodone. Local governments and individuals must also ...

OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it ...

Attorneys general from 55 U.S. states and territories signed onto a $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the country's opioid epidemic, officials ...

OxyContin maker Purdue Pharma's latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. Related video above: FDA ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday ...

Purdue opioid settlement could pay more than $850 million to victims if it advances Potentially more than $850 million from the settlement would go directly to individual victims.